• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Oxygenta Pharmaceutical Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 19443.0
  • ISIN : INE102E01018
79.56 0 (-0.51%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    77.00

  • Today’s High

    79.58

  • Open

    77.00

  • Perv Close

    79.97

  • 52W Low

    28.02

  • 52W High

    108.64

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    294.24

  • Div & Yield %

    0.00

  • Book Value(₹)

    -5.11

  • Debt-Equity Ratio

    -0.51

  • AGM Date

    28-Mar-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    294.24

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    36.98

  • BV (₹)

    -5.10

  • Sales( ₹ in Cr.)

    39.64

  • NP (in Cr.)

    -3.52

  • NP Var(%)

    68.0

  • Div%

    0.0

  • CPS (₹)

    -0.20

  • EPS (₹)

    -1.00

  • Traded Value (₹ in Lakhs)

    294.24

  • 52 Week High

    108.64

  • 52 Week Low

    28.02

  • Price BSE

    80.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    294.24

  • P/C Ratio

    -345.80

  • P/E Ratio

    -84.10

  • Price Vs.BV

    -1.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 39.64 30.99 60.52 52.03 13.72 20.51
Excise Duty 39.64 30.99 60.52 52.03 13.72 20.51
Net Sales 39.64 30.99 60.52 52.03 13.72 20.51
Other Income 0.04 0.02 0.00 0.09 0.03 0.31
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 39.68 31.01 60.53 52.12 13.75 20.82
EXPENDITURE :
Raw Materials 39.64 30.99 60.52 52.03 13.72 20.51
Power & Fuel Cost 39.64 30.99 60.52 52.03 13.72 20.51
Employee Cost 5.99 5.86 0.70 4.19 2.50 3.21
Other Manufacturing Expenses 0.02 0.01 0.01 0.01 0.01 0.06
Selling & Administrative Expenses 2.36 1.63 1.76 1.68 1.17 0.93
Miscellaneous Expenses 0.02 0.01 0.01 0.01 0.01 0.06
Less : Pre-operative Expenses Capitalised :
Total Expenditure 53.59 41.64 61.57 51.16 23.68 24.31
Operating Profit 7.44 6.59 9.35 5.67 2.32 2.28
Interest 1.59 1.49 0.92 1.78 1.09 0.75
Gross Profit -13.87 -11.37 -0.49 3.14 -5.94 -3.49
Depreciation 2.66 2.05 1.59 1.20 1.00 1.02
Profit Before Tax -13.87 -11.37 -0.49 3.14 -5.94 -3.49
Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -10.39 0.20 0.12 0.21 -0.15 -0.24
Reported Net Profit -3.48 -11.57 -0.61 2.93 -5.79 -3.25
Extraordinary Items -13.87 -11.37 -0.49 3.14 -5.94 -3.49
Adjusted Net Profit -3.48 -11.57 -0.61 2.93 -5.79 -3.25
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -3.48 -11.57 -0.61 2.93 -5.79 -3.25
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.09 -8.15 -0.48 2.87 -5.67 -3.19
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    51.12%

  • Public Share Holding

    48.88%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 200,000 0.54 200,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,706,202 50.58 18,706,202 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 18,906,202 51.12 18,906,202 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 9,700 0.03 0 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,700 0.03 0 3
2] Non Institution
Bodies Corporate 116,466 0.31 98,766 86
Clearing Members 4,601 0.01 4,601 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,701,466 4.60 1,699,466 14
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 13,370,759 36.15 13,348,759 43
Individuals holding nominal share capital up to Rs. 1 lakh 2,874,306 7.77 1,586,476 9,944
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 18,067,598 48.85 16,738,068 10,093
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 36,983,500 100.00 35,644,270 10,107

Company Background

Oxygenta Pharmaceutical LtdPharmaceuticals - Indian - Bulk Drugs

  • Oxygenta Pharmaceutical Ltd
  • BSE Code : 19443.0
  • ISIN : INE102E01018

  • Incorporation Year

    1990

  • Registered Office

    Survey No 252/1 Aroor Village
    Sadasivapet Mandal, Medak,
    Telangana-502291

  • Telephone

    91-08455-250080/250280

  • FAX

    91-08455-250090

  • Chairman

    Sai Sudhakar Vankineni

  • Managing Director

    Sai Sudhakar Vankineni

  • Company Secretary

    Dolly Mandhan

  • Auditor

    A M Reddy & D R Reddy

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Oxygenta Pharmaceutical Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Oxygenta Pharma 79.56 39.68 39.64 -1,989.00 0.00
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92